Antifungal activity of antimicrobial-impregnated devices

Clinical Microbiology and Infection

Volumn 12, Issue 4, 2006, Pages 397-399

  Darouiche, R O ^a   Mansouri, M D ^a   Kojic, E M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Candida albicans; Candida krusei; Chlorhexidine; Chloroxylenol; Impregnated devices; Rabbit model

Indexed keywords

CEFAZOLIN; CHLORHEXIDINE; CHLOROXYLENOL; SILICONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL THERAPY; ARTICLE; CANDIDA ALBICANS; CANDIDA KRUSEI; CANDIDIASIS; CATHETER; CATHETER INFECTION; COLONY FORMING UNIT; CONTROLLED STUDY; DEVICE REMOVAL; DRUG EFFICACY; FEMALE; FUNGAL COLONIZATION; IN VITRO STUDY; IN VIVO STUDY; INFECTION RISK; NONHUMAN; PRIORITY JOURNAL; RISK REDUCTION; SKIN INFECTION;

ANIMALIA; CANDIDA ALBICANS; ISSATCHENKIA ORIENTALIS; ORYCTOLAGUS CUNICULUS;

EID: 33644758269     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01369.x     Document Type: Article

References (16)

1. Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev 2004; 17: 255-267.
2. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond EB. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-317.
3. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States Hospitals: A three-year analysis. Clin Infect Dis 1999; 29: 239-244.
4. Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices. Clin Infect Dis 2002; 34: 1232-1242.
5. Darouiche RO. Device-associated infections: A macroproblem that starts with microadherence. Clin Infect Dis 2001; 33: 1567-1572.
6. Darouiche RO, Safar H, Raad II. In vitro efficacy of antimicrobial-coated bladder catheters in inhibiting bacterial migration along catheter surface. J Infect Dis 1997; 176: 1109-1112.
7. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: A randomized, controlled trial. Ann Intern Med 1997; 127: 257-266.
8. Raad I, Darouiche R, Dupuis J et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: A randomized, double-blind trial. Ann Intern Med 1997; 127: 267-274.
9. Darouiche RO, Raad II, Heard SO et al. A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 1999; 340: 1-8.
10. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med 2004; 350: 1422 1429.
11. Mermel LA, Farr BM, Sherertz RJ et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32: 1249-1272.
12. Raad I, Hanna H, Boktour M et al. Management of central venous catheters in patients with cancer and candidemia. Clin Infect Dis 2004; 38: 1119-1127.
13. Rex JH, Bennett JE, Sugar AM et al. Intravascular catheter exchange and duration of candidemia. Clin Infect Dis 1995; 21: 994-996.
14. Sherertz RJ, Carruth WA, Hampton AA, Byron MP, Solomon DD. Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits. J Infect Dis 1993; 167: 98-106.
15. Darouiche RO, Green G, Mansouri MD. Antimicrobial activity of antiseptic-coated orthopaedic devices. Int J Antimicrob Agents 1998; 10: 83-86.
16. Darouiche RO, Farmer J, Chaput C, Mansouri M, Saleh G, Landon GC. Antiinfective efficacy of antiseptic-coated intramedullary nails. J Bone Joint Surg 1998; 80A: 1336-1340.